Empery Digital Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Empery Digital Inc. (NASDAQ: EMPD) on February 3, 2026, covering events occurring on February 2 and February 3, 2026. The Company is an emerging growth company incorporated in Delaware. The filing primarily addresses the implementation of a shareholder rights plan (poison pill) and an expansion of the Company's share repurchase program.
Key Financial Metrics and Capital Actions
The filing does not report standard operating financial metrics such as revenue, net income, operating cash flow, or debt levels. However, it discloses specific capital allocation data related to the share repurchase program:
- Repurchase Authorization: The Board authorized an additional $50 million, bringing the total authorized amount to $200 million.
- Shares Repurchased: As of February 2, 2026, the Company has repurchased 14,264,933 shares.
- Average Purchase Price: The average price paid for repurchased shares is $6.90 per share.
- Remaining Capacity: Approximately $102 million remains available for future repurchases under the program.
- Program Expiration: The authorization is effective through July 24, 2027.
Material Changes and Corporate Actions
The filing details two significant material changes to the Company's capital structure and governance:
- Shareholder Rights Plan (Poison Pill):
- The Board declared a dividend of one preferred share purchase right (Right) for each outstanding common share.
- Record Date: February 13, 2026.
- Trigger Threshold: Rights separate and become exercisable if any person acquires 12.5% or more of the outstanding common stock (Acquiring Person).
- Flip-in Provision: Upon a trigger event, holders (excluding the Acquiring Person) may purchase common stock with a value equal to two times the exercise price ($15.00 per 1/1000th preferred share).
- Expiration: Rights expire on February 2, 2027, unless redeemed or triggered earlier.
- Series A Preferred Stock Designation:
- A Certificate of Designations was filed to create Series A Preferred Stock, which serves as the underlying security for the Rights.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, revenue outlook, or management commentary on future operating performance. The primary risks and contingencies disclosed relate to the Rights Agreement:
- Anti-Takeover Effect: The Rights Plan is designed to deter unsolicited takeover attempts by making an acquisition prohibitively expensive for an Acquiring Person.
- Redemption: The Board retains the right to redeem the Rights at $0.00001 per Right at any time prior to a trigger event.
- Qualifying Offer Exemption: The Rights will automatically expire if a qualifying tender offer is accepted for more than two-thirds of the outstanding shares, provided the offeror commits to purchasing remaining shares.
Investor Verification Checklist
- Verify the exact number of common shares outstanding as of the February 13, 2026 Record Date to calculate the total number of Rights issued.
- Review the full text of the Rights Agreement (Exhibit 4.1) for specific definitions of "Acquiring Person," "Beneficial Ownership," and derivative position exclusions.
- Monitor future filings for any redemption of the Rights or changes to the 12.5% trigger threshold.
- Track the execution of the $102 million remaining share repurchase authorization to assess management's view on stock valuation.
- Confirm the status of the Series A Preferred Stock designation in the Delaware Secretary of State records.